Men and women with indolent, or low-grade, non-Hodgkin’s lymphoma are needed for a clinical trial that evaluates medication of adults previously treated for the cancer.

The hospital is seeking adults ages 18 and older with B-cell indolent non-Hodgkins lymphoma for a Phase III clinical trial, a stage of final confirmation of safety and efficacy of a treatment, hospital officials said in a news release.

“Drugs that successfully pass Phase III are usually approved by the national regulatory authority for use in the general population,” the news release says.

Interested patients will be advised of the potential risks and benefits of the clinical trial. If they choose to participate, they will be closely monitored by medical staff throughout the process, hospital officials said.

“When patients participate in a clinical trial, they are not only advancing medical technology, they are providing a valuable benefit to future generations. The goal of clinical trials at Lafayette General Health is to support the patient-centered approach to health care,” the news release says.

For information on this and other clinical trials available at Lafayette General Medical Center, call (337) 289-8658.